Shegog Todd — SEC insider filings
SEC reporting owner CIK 1714564. 13 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2021-02-24 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,687 shares, $55,605 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 5,687 shares @ $9.78 ($55,605) in Forma Therapeutics Holdings, Inc., filed 2022-02-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. (FMTX) | SVP, Chief Financial Officer | 4 | — | 1 leg · 5,687 sh · $55,605 | 12 |
| Cogent Biosciences, Inc. (COGT) | Director | 7 | — | — | 7 |
| InMed Pharmaceuticals Inc. (MTRI) | Director | 2 | — | — | 1 |
Insider filings — Shegog Todd
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 3 | InMed Pharmaceuticals Inc. (MTRI) | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 4 | InMed Pharmaceuticals Inc. (MTRI) | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 17,901 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 44,700 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 36,700 (derivative) @ $0 | EDGAR |
| 2022-10-14 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Code (U): 56,143 · Disposition to issuer (D): 153,528 (derivative) · Disposition to issuer (D): 11,689 (derivative) · Disposition to issuer (D): 116,890 (derivative) · Disposition to issuer (D): 70,134 (derivative) · Disposition to issuer (D): 50,250 (derivative) · +1 more | EDGAR |
| 2022-06-09 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 30,700 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Grant/award (A): 33,330 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Sale (S): 5,687 @ $9.78 | EDGAR |
| 2021-03-15 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Forma Therapeutics Holdings, Inc. (FMTX) | Grant/award (A): 16,500 @ $0 · Grant/award (A): 12,000 @ $0 · Grant/award (A): 50,250 (derivative) @ $0 | EDGAR |
| 2021-02-24 | 4 | Cogent Biosciences, Inc. (COGT) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1714564 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs